Robert Langreth

Stay informed with Robert Langreth’s coverage and analysis for Fortune.

Page 3 of 4

TADWORTH, ENGLAND – NOVEMBER 10: A general view of the Pfizer UK Headquarters sign on November 10, 2020 in Tadworth, England. Opened in 2002, the 320-acre site houses the company’s UK commercial headquarters. According to the Pfizer website, the location’s approximately 700 employees work in business-support functions, such finance or HR, and European business operations. The American pharmaceutical company recently announced its novel coronavirus vaccine, developed with German firm BioNTech, was 90% effective in trials. (Photo by Dan Kitwood/Getty Images)
Pfizer and partner BioNTech said on Wednesday that final analysis of clinical trial data showed their COVID-10 vaccine trial are 95% effective. Wire photography: Dan Kitwood—Getty Images

Pfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective

By Robert Langreth and Bloomberg

Moderna says its COVID-19 vaccine is 94.5% effective

By Robert Langreth and Bloomberg

Investors sent Moderna shares higher on Wednesday as the company’s COVID-19 vaccine shows promise in the latest trials. Wire photography Illustration by Jakub Porzycki—NurPhoto via Getty Images

Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s

By Robert Langreth and Bloomberg

ANKARA, TURKEY – OCTOBER 27: Injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company, are seen at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate, within the scope of phase 3 studies, was injected to volunteers in Ankara University Ibni Sina Hospital. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)

Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections

By Robert Langreth, Naomi Kresge, and others

Gilead shares jump on FDA approval of remdesivir

By Robert Langreth and Bloomberg

BRAZIL-HEALTH-VIRUS-VACCINE

AstraZeneca COVID-19 vaccine enters final-stage trial in the U.S.

By Robert Langreth and Bloomberg

Moderna COVID-19 Vaccine Trial Underway in DeLand, Florida

Trump administration strikes another deal for a promising COVID-19 vaccine

By Olivia Raimonde, Robert Langreth, and others

BRAZIL-CHINA-HEALTH-VIRUS-VACCINE-TRIAL

Experts share a clearer timeline of when most Americans will get COVID-19 vaccine

By Anna Edney, Josh Wingrove, and others

Gilead coronavirus treatment drug Remdesivir

Gilead to charge thousands for coronavirus treatment drug that critics say should cost $1

By Robert Langreth and Bloomberg

Coronavirus test used at White House faces accuracy questions

How accurate are the coronavirus tests used by the White House? A new report is raising questions

By Michelle Fay Cortez, Robert Langreth, and others

Gilead remdesivir price

Gilead shares tumble on reports that the Chinese trial of its coronavirus drug was not successful

By Drew Armstrong, Robert Langreth, and others

Young people are getting sick from coronavirus.

Young people are getting extremely sick from coronavirus, according to new evidence

By Michelle Cortez, Angelica LaVito, and others

An emergency worker in protective clothing drives an ambulance carrying a person diagnosed with Covid-19 from the Diamond Princess cruise ship, on Feb. 13, 2020 in Yokohama, Japan.

‘Tip of the iceberg:’ Why Covid-19 deaths will keep rising even as the coronavirus outbreak wanes

By Robert Langreth, Michelle Fay Cortez, and others

No guns sign

Walgreens Joins Walmart and Kroger in Saying Open-Carry Firearms Are Not Welcome in Stores

By Polly Mosendz, Robert Langreth, and others

Rite Aid Pharmacy

Rite-Aid Pharmacy Chain Tries to Heal Itself: C-Suite Execs Are Out, 400 Jobs Will Be Cut

By Robert Langreth and Bloomberg